Sickle cell disease in the kidney transplant

Kidney Int. 2024 Apr;105(4):892. doi: 10.1016/j.kint.2023.09.022.

Authors

Lynn D Cornell¹, Divya Shankaranarayanan², Pablo Serrano Rodriguez³, Sibel Erdogan Damgard⁴

Affiliations

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: cornell.lynn@mayo.edu.
² Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC, USA.
³ Division of Transplant Surgery, George Washington University School of Medicine, Washington, DC, USA.
⁴ Microscopy and Cell Analysis Core, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 38519242
DOI: 10.1016/j.kint.2023.09.022

No abstract available

Publication types

Case Reports

MeSH terms

Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / diagnosis
Anemia, Sickle Cell* / therapy
Humans
Kidney Transplantation* / adverse effects
Transplantation, Homologous